In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hurry Up and Wait: The Slowdown in Accelerated Approvals

Executive Summary

Accelerated approvals are decelerating. Sponsors argue the FDA is so caught up in the current emphasis on safety that they're raising the AA efficacy standards. The FDA contends that the companies who have been rejected aren't meeting the efficacy standards or performing the promised follow-up trials. Is the FDA changing the rules-or are companies themselves bending them? A look at several recent cases of AA therapies reveals that both are true.
Advertisement

Related Content

Nothing Random About It: The State of Cancer Drug Development at FDA
Nothing Random About It: The State of Cancer Drug Development at FDA
Nothing Random About It: The State of Cancer Drug Development at FDA
Rethinking Alzheimer's: Mapping Out an Approval Process
Flying Through FDA: Test Runs For Pilot 1
Flying Through FDA: Test Runs For Pilot 1
A Little Knowledge: The FDA's Public Approach to Safety
Problems With Biomarkers: A Tale of Three Drugs
Problems With Biomarkers: A Tale of Three Drugs

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV002603

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel